Skip to content

Esperion Therapeutics ESPR Income Taxes Paid, Net

Income Taxes Paid, Net at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$37K+363%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$1.43M+143,000%

Other financials

Income statement

See full
Revenue$80.1M+23.2%
Operating income-$6.6M+70.2%
Net income-$25.2M+37.7%
EPS (diluted)-$0.10+52.4%

Balance sheet

See full
Cash & equivalents$156.2M+36.2%
Total debt$155.2M+6.1%
Total equity-$307.9M+27.8%
Total assets$462.5M+42.7%

Cash flow

See full
Operating cash flow-$27.7M-22.5%
CapEx$189.0K
Free cash flow-$27.9M-23.3%

Valuation

See full
Market cap$811.73M+283%
Enterprise value$810.81M+233%
P/S1.9×+1.1×

Profitability

See full
Operating margin18.1%+12.7pp
Net margin-34.8%+8.0pp
FCF margin-30.7%

Returns & leverage

See full
Return on equity-260.8%
Debt / equity0.8×
Current ratio1.5×+0.4×

Where this comes from

Reported directly by Esperion Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaidNet.

The official record: Esperion Therapeutics’s 10-K, filed March 10, 2026, on SEC EDGAR. View the filing →

Ask your AI about Esperion Therapeutics's income taxes paid, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Esperion Therapeutics's income taxes paid, net?
Esperion Therapeutics (ESPR) reported income taxes paid, net of $153K in Q4 2025.
What does income taxes paid, net mean?
This represents the actual cash outflow for income taxes during the period, net of any refunds received. Unlike the income tax expense reported on the income statement, this figure reflects the timing of actual tax payments to government authorities. It is a key indicator of the company's effective cash tax rate and its ability to manage tax liabilities.